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Abstract
Background The aim of this study was to assess whether
partially absorbable monofilament mesh could influence
postoperative pain and recurrence after Lichtenstein her-
nioplasty over the long term.
Methods Patients were randomized into two groups that
were treated with lightweight (LW) or heavyweight (HW)
mesh in 15 centers in Poland. A modified suture technique
was used in the lightweight mesh group. Clinical exami-
nation was performed. A pain questionnaire was completed
five years after the surgery.
Results Of the 392 patients who underwent surgery, 161
(90.81 %) of 177 in the HW group and 195 (90.69 %) of 215
in the LW group were examined according to protocol, a
median of 62 (range 57–66) months after hernia repair. There
was no difference in the recurrence rate (1.9 % LW vs. 0.6 %
HW; P = 0.493). There were 24 deaths in the follow-up
period, but these had no connection to the surgery. The
patients treated with LW mesh reported less pain in the early
postoperative period. After five years of follow-up, the
intensity and the presence of pain did not differ between
groups (5 patients in the LW and 4 patients in the HW group).
Average pain, (VAS score), was also similar in the LW and
HW group (2.25 vs. 2.4) at the fifth year postoperatively.
Conclusion The use of partially absorbable mesh reduced
postoperative pain during the short-term postoperative
period. No difference in pain or recurrence rate was
observed at 60 months.
Keywords Inguinal hernia  Lichtenstein 
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Introduction
Tension-free mesh repair currently represents the gold
standard in inguinal hernia surgery [1]. To date, meshes of
many different shapes, varied chemical structure, and dif-
fering designs have been introduced into medical practice.
The Lichtenstein method is still the most popular. Although
the use of prosthetic materials reduced the rate of recur-
rence [1], it may be associated with chronic pain [2, 3].
Meshes built of dense woven propylene, the substance
most commonly used in the production of prosthetic
materials in hernia surgery, are characterized by low bio-
compatibility [3]. This feature induces a potent immuno-
logic response from the surrounding tissue, which may lead
to the development of chronic pain, which was assessed in
many trials to be present in more than 20 % of patients [4].
Efforts to address this problem over the last decade have led
to the technological development of a new generation of
lightweight meshes. Theoretically, these meshes should
decrease the inflammatory response and reduce the rates of
chronic pain. Recently published trials have proven that the
use of lightweight meshes reduces the rate of chronic pain
rate over the short term as compared to heavyweight
polypropylene meshes [5–8]. Nonetheless, an increased rate
of recurrence was demonstrated in one trial, suggesting the
need for further characterization of this material.
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The aim of this study was to assess whether partially
absorbable monofilament mesh could influence postoperative
pain and the recurrence of pain after tension-free hernioplasty
(Lichtenstein method). Results obtained during the first
month demonstrated a decreased rate of pain and no increase
in the risk of recurrence. However, longer observation will be
required to adequately assess the rate of recurrence.
Patients and methods
Patients aged between 20 and 75 years diagnosed with
primary, unilateral inguinal hernia were eligible to partic-
ipate in the study. All the exclusion criteria were published
previously [8]. Patients were recruited and then operated
upon in 15 selected hospitals in Poland. All patients were
informed about the study protocol and provided their
informed consent. The study protocol was approved by the
Ethical Committee of the Medical University of Gdansk,
which represented all of the participating hospitals. The
randomization process was performed just before the sur-
gery, with the use of a Wichmann–Hill pseudorandom
number generator (modified by McLeod).
All patients were operated upon by experienced sur-
geons using the standard Lichtenstein procedure. Investi-
gators could not participate in the study unless each had
performed a minimum of 200 Lichtenstein procedures.
Before the start of the study, a workshop related to oper-
ative technique and its modification was conducted for all
trial participants.
The heavyweight polypropylene mesh (Prolene; Ethi-
con, Hamburg, Germany) that was used weighed over 80
g/m2. The other alternative was a lightweight, braided,
monofilament mesh with large pores made from poligle-
caprone and polypropylene (Ultrapro; Ethicon, Hamburg,
Germany). Analyzing the properties of Ultrapro mesh, we
noted that after shaping the mesh, the pores of some
margins seemed to be closed. Suturing and straining can
unravel those pores and rip the suture. Based on these
findings, and on the mesh elasticity, three suturing modi-
fications were applied to the basic Lichtenstein technique
in the lightweight group. A larger suture margin (minimum
four pores of lightweight mesh) and about a two times
shorter distance between the steps (maximum 1 cm) was
used for running suture on the inguinal ligament. One
additional suture was placed to fix the mesh near the pubic
bone between the pubic tubercle and the middle line.
The specific anesthesia, prophylactic antibiotics, post-
operative analgesic procedures, and drugs used have been
published previously [8].
All data were collected on paper forms by a blinded
surgeon during planned follow-up visits. Filled forms were
sent to the steering committee secretary in Gdansk. The
information therein was entered into the computer database
by one of the investigators. Before closing the database, all
files were checked to find any additional unreported com-
plications or serious violation of the study protocol. The
immediate and short-term postoperative results were pub-
lished in a previous publication [8].
After five years had elapsed from the time of the sur-
gery, all participating patients were contacted by telephone
or in person by one of the investigators. Patients reporting
groin pain or foreign body sensations, as well as those
suspected of recurrence, were physically examined. If there
was any doubt, USG was performed. The VAS scale (1–10)
was used to assess pain.
Statistical analysis
The hypothesis was that using lightweight mesh would
result in less pain during the short- and long-term follow-
up periods.
The number of patients required for statistical power in
each group was calculated under the assumption that a
reduction in pain incidence from 20 to 10 % at three
months would be clinically significant. With this assump-
tion, 80 % test power, and an alpha level of 0.05, it was
determined that 210 individuals were needed in each group.
Ultimately, 300 patients were included in each group due
to the anticipation of patient losses. The details relevant to
patient allocation were previously published [8]. It is to be
mentioned that exclusion of the hospitals was conducted to
avoid main bias often find in the RCT’s. The investigators
inherent bias could potentially lead to positive false results
in the composite mesh group. Due to this fact, the moni-
toring committee has excluded whole patients lists (in the
case of serious violation of the protocol found in more than
1 % of patients CRF) from the center (both groups) to
avoid also the exclusion bias (elimination of worst results
in the treated group) in the study.
All the statistical calculations were performed using
Statistica 7.1 PL (Polish version) software (StatSoft, Tulsa,
Oklahoma, USA). The tests used were as follows: Student‘s
t test, Shapiro–Wilk’s W test, Mann–Whitney‘s U test,
ANOVA, and chi-square test (with Yate’s correction when
needed and double-sided to check the alternative hypothesis
that the probability of an observation is less than expected
under the null hypothesis). P \ 0.05 was considered sta-
tistically significant. Multivariate analysis was performed to
find factors influencing postoperative pain.
Results
A total of 600 men were randomized, 300 to standard
treatment and 300 to treatment with the LW mesh. After
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monitoring visits, there were 215 patients in the LW mesh
group and 177 in the HW mesh group. There were no
significant differences between the groups [8].
Of 392 patients who underwent surgery, 161 (90.81 %)
of 177 in the polypropylene mesh group and 195 (90.69 %)
of 215 in the poliglecaprone and polypropylene composite
mesh group were examined according to protocol, a med-
ian of 62 (range 57–66) months after hernia repair. There
were 24 deaths during the follow-up period, but without
any connection to the surgery (Fig. 1).
The first follow-up study reported a total of five hernia
recurrences, four in the lightweight group and one in the
polypropylene mesh group, after 1 year [8]. The recurrence
rate had not increased at the time of this clinical assess-
ment, yielding recurrence rates of 1.86 % (2.05 % if dead
patients or lost to follow-up were excluded) and 0.57 %
(0.62 % if dead patients or lost to follow-up were exclu-
ded), respectively, after LW and polypropylene mesh
repair (P = 0.493).
There were no major differences in response to the pain
questionnaire. Four patients in the heavyweight mesh
group and five patients in the lightweight mesh group were
reporting pain. The average VAS score (with respect to
pain) was 2.25 (range, 2–3) in the LW mesh group and 2.4
(range, 2–3) in the polypropylene mesh group. This dif-





Allocated to composite mesh n =300
Received intervention n = 300
Allocated to standard mesh n =300
Received intervention n =300
Excluded from analysis n = 85*
Give reasons  n = 85*
Excluded from analysis n =123*
Give reasons  n =123*
Included to follow-up chart n = 215+
Lost to follow-up n = 7
Give reasons n = 3
Discontinued intervention n = 4
Give reasons  n = 4 (recurrence)
Included to follow-up chart n = 177+
Lost to follow-up n = 5
Give reasons n = 2
Discontinued intervention n = 1
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Discontinued intervention n = 0
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Lost to follow-up n = 16
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Discontinued intervention n = 0





Fig. 1 Randomized trial of composite lightweight or polypropylene
mesh in Lichtenstein primary inguinal hernia repair. plus sign
Included into final analysis after the monitoring visits in the hospitals,
asterisk exclusion after monitoring visits in hospitals—see description
in section: study flow chart; filled diamond published previously [8]
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center was found as a high volume one for recurrence or
pain.
In a multivariate analysis made for the whole group of
patients, two factors were found as influencing the presence
of pain after the operation type of the mesh used (in
3 month postoperatively [P = 0.046] and the presence of
pain before the operation noted in 3 month [P = 0.0007]
and 6 month [P = 0.0017] after operation.
Discussion
In this multicenter study, we showed that using partially
absorbable lightweight mesh as opposed to standard
heavyweight polypropylene mesh did not result in an
improved pain profile or a different recurrence rate at the
time of 60-month follow-up.
In recent years, many studies have shown that the use of
mesh decreases acute pain (up to 12 months) in compari-
son to tension methods. Acute pain affects up to 20 % of
patients who undergo surgery with mesh [9–11]. Experi-
mental studies showed that the extent of the foreign body
reaction, with the scar tissue and inflammatory reaction it
provokes, depends on the amount and physical structure of
the prosthetic material that is used [4]. To solve this
problem, medical companies are trying to improve the
materials available and introduce new ones. Trials pub-
lished by S´mietan´ski et al. [12], O’Dwyer et al. [6], and
Post et al. [5] confirmed that reducing the weight of the
mesh by adding an absorbable component decreases the
level of pain by half over the short term (3–6 months
postoperatively). However, Bringman et al. [7] did not find
significant differences in pain scores at 1 and 3 years
postoperatively. Unfortunately, no metaanalysis of the tri-
als mentioned previously has been performed. Notably,
pain score can vary depending on the protocol used in a
particular study. Bringman reported an incidence of pain
that ranged from 1 to 24 % during the first 3–6 months.
This difference disappeared after 6 months of observation,
due to the low incidence of pain in both groups. Other trials
have supported the use of a lightweight material [12]. Only
one trial comparing weight-reduced material over the long
term is currently available. This study reported the lack of
any influence of the mesh on the long-term rate of pain
after 60 months of observation, but the lightweight mesh
used varied in design from that used in other trials [12].
Notably, Ultrapro is more elastic and macroporous in
construction than Surgimesh WN (a polypropylene plate
made from microfibres), which should result in the for-
mation of a more elastic scar in the inguinal canal. Still, our
findings did not confirm that the difference in weight of the
mesh is responsible for the 0.43 % frequency of pain
among patients treated with Ultrapro as opposed to the 2 %
frequency of pain among those treated with the composite
mesh [12]. Use of the lightweight material as compared to
the heavyweight mesh did not provide the patient with any
benefit over the long term. Notably, the frequency of pain
among patients in the polypropylene group was less than
2 %, which is comparable with values reported by other
groups [1].
Over recent decades, the use of prosthetic material has
reduced the recurrence of hernia. The development of new
materials has renewed focus on the topic. In some studies,
the recurrence rate was higher among patients treated with
lightweight mesh, but this trend was significant (5.6 %) in
only one group [6]. O’Dwyer stated that the high rate of
recurrence is a consequence of the prosthetic material’s
physical features, which require modification of the fixa-
tion technique that is commonly used. The modifications
applied in our trial reduced the recurrence rate to an
acceptable level of 2 % during the first 5 years postop-
eratively, similar to the level reported by the case series
that treated patients using Ultrapro mesh [13]. It is
important to note that in different case series published for
Ultrapro mesh the recurrence occurred mostly in the
patients treated by residents in emergency settings or in
patients with serious comorbidities, who were excluded in
our trial, what can potentially influence the results (false
positive effect of all RCT’s) [13]. The used modification
must also be introduced in surgical practice before
launching the mesh in a new hospital to avoid the increase
in recurrence (like in O’Dwyer trial) [6]. In the presented
trial, we have noted that the recurrences occurred in the
first postoperative year, what corresponds with another
long-term observational studies, for example, conducted
by van Veen et al. (recurrence in the mesh group noted in
first 2 years postoperatively only) [10]. Still it is possible
that in our trial some recurrences could been missed
(asymptomatic small recurrence) due to telephone exam-
ination of the patients.
We believe that presented trial adds also a new material
potentially influencing the guidelines in inguinal hernia
surgery [14]. Authors of the EHS guidelines have recom-
mended the use of lightweight material considering the
potential increase in recurrence rate, according to different
results of available trials. The data from our study and
other randomized studies might influence the conclusion of
the EHS guidelines on lightweight materials.
Conclusion
Data collected after 60 months of observation did not show
any significant difference in recurrence and pain between
the lightweight mesh and heavyweight mesh groups, con-
firming previously published conclusions about its use.
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When considering short-term follow-up as a primary end-
point, a lightweight material should be the first choice,
despite the lack of any benefit for patients over the long
term.
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